Carolyne Zimmermann
Carolyne is a General Partner at dRx Capital, a joint investment company between Novartis Pharma and Qualcomm Ventures, a $100M venture investment firm focusing on early stage companies in the digital medicine space.
San Francisco, California, United States
Accredited investor
Member since February 22, 2016
- About
Investor interests
| Type of investor | Early stage VC Growth stage VC Corporate Venture |
| Typical investment size | More than $2.5M |
| Typical investments in a year | 4 |
| Categories of interest | |
| Locations of interest | |
| Credentials | Accredited Investor |
Activity
| Investments made | Cala Health, Science 37, Omada Health |
I am a(n):
Investor
